The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels


Sanli Y., Kuyumcu S., Ozkan Z. G., Kilic L., Balik E., Turkmen C., ...Daha Fazla

ANNALS OF NUCLEAR MEDICINE, cilt.26, sa.7, ss.551-558, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 7
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1007/s12149-012-0609-0
  • Dergi Adı: ANNALS OF NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.551-558
  • Anahtar Kelimeler: Colorectal cancer, Recurrence, CEA levels, FDG-PET/CT, POSITRON-EMISSION-TOMOGRAPHY, CARCINOEMBRYONIC ANTIGEN, COMPUTED-TOMOGRAPHY, F-18-FDG PET, RESECTION, IMPACT, METASTASES, SURVIVAL, CT
  • İstanbul Üniversitesi Adresli: Evet

Özet

Tumor recurrence of colorectal cancers (CRC) is generally followed up by analyses of the serum carcinoembryonic antigen (CEA) levels. However, recent evidence suggests that tumor recurrence can also be visualized by 18F-fluoro-deoxyglucose emission tomography/computed tomography (FDG-PET/CT) in patients with normal CEA levels. We retrospectively evaluated the diagnostic performance of FDG-PET/CT in patients with suspected recurrence of CRC by comparing PET/CT performance in patients with normal CEA levels with PET/CT performance in patients with elevated CEA levels.